Posted on August 7, 2017 by Sitemaster
One really has to wonder whether we are still treating elderly men, initially diagnosed with organ-confined prostate cancer, with first-line or “primary” androgen deprivation therapy ADT)! And if we are, why on Earth is that? … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: ADT, androgen, appropriate, deprivation, elderly, organ-confined, primary | 4 Comments »
Posted on February 2, 2017 by Sitemaster
So a relatively new article in Reviews in Urology caught your Sitemaster’s eye this morning — and worried him because it seemed to be communicating a conclusion of questionable accuracy, which we will explore below. And if we have misinterpreted the data provide in the paper, we are more than willing to be corrected. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: biopsy, elderly, Gleason score, PSA, risk, stage, Treatment | Leave a comment »
Posted on January 11, 2017 by Sitemaster
A helpful review article on the treatment of metastatic and metastatic, castration-resistant prostate cancer (mCRPC) in very elderly men appears in last month’s issue of Clinical Interventions in Aging. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: castration-resistant, elderly, guideline, metastatic, Treatment | 2 Comments »
Posted on July 6, 2015 by Sitemaster
A group of Italian clinicians and researchers have reported that low-dose abiraterone acetate along with very low-dose prednisone appears to be both effective and safe in the treatment of elderly patients between 85 and 93 years of age with castration-resistant prostate cancer (CRPC). … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: abiraterone, dose, elderly, food, prednisone | 9 Comments »
Posted on September 12, 2012 by Sitemaster
In a newly published article in the American Journal of Clinical Oncology, Mishra et al. have attempted to assess the application of immediate, first-line treatment among older men with favorable-risk prostate cancer. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: active surveillance, decision, elderly, low, risk, Treatment, very lw | Leave a comment »
Posted on December 14, 2011 by Sitemaster
Now here’s a new perspective on the value of widespread prostate cancer screening from one of the founders of Prostate Cancer Awareness Week — Dr. David Crawford of the University of Colorado Health Science Center in Denver, CO (who is also the Chairman of the Prostate Conditions Education Council): … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: elderly, screening, testing, value | 2 Comments »
Posted on December 13, 2011 by Sitemaster
The value of regular testing of increasingly elderly men and women for risk of cancer is controversial. However, a new paper in the Archives of Internal Medicine has certainly added to our knowledge of just how widespread such testing may be … at least in the USA. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: elderly, recommendation, screening, testing | 9 Comments »
Posted on October 19, 2011 by Sitemaster
According to a media release from the University of Rochester, a new study suggests that “men age 75 and older are diagnosed with late-stage and more aggressive prostate cancer and thus die from the disease more often than younger men.” … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: disgnosis, elderly, metastasis, mortality | 6 Comments »
Posted on October 4, 2011 by Sitemaster
A population-based analysis of mortality data for men diagnosed with prostate cancer from three European nations suggests that “a small but important group of older patients” initially present with late stage prostate cancer and die rapidly as a consequence. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: Diagnosis, elderly, mortality, stage, survival | 11 Comments »
Posted on August 25, 2011 by Sitemaster
Data reported earlier this year from the PIVOT study and separately from the long-term Scandinavian study have shown that the surgical treatment of prostate cancer in the patients enrolled in these trials showed no median prostate-cancer specific or overall survival benefit compared to watchful waiting in patients of > 65 years of age. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: "high risk", age, elderly, old, radical prostatectomy, RALP, robot-assisted | 2 Comments »
Posted on July 22, 2011 by Sitemaster
Based on data collected in the Cryo On-Line Database (COLD), Dhar et al. have just published an analysis of data from a total of 860 men, all over 75 years of age, who were treated with whole-gland cryoablation for clinically localized prostate cancer at times dating back to at least 1995. … READ MORE …
Filed under: Diagnosis, Management, Risk, Uncategorized | Tagged: croablation, cryotherapy, elderly, outcome, risk, whole-gland | 1 Comment »
Posted on July 20, 2011 by Sitemaster
Two recent publications have offered evidence that, at 10 and 12 years of follow-up, the potential benefits of surgical treatment for low- and intermediate-risk prostate cancer did not include any impact on overall survival for men of 65 years of age or more at the time of surgery. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: benefit, complication, elderly, localized, outcome, over-treatment, risk, side effect | 2 Comments »
Posted on December 9, 2010 by Sitemaster
Overall life expectancy of men in the US continues to rise. As a consequence, the way we treated localized prostate cancer in men of ≥ 70 years of age in 1990 will probably not be relevant or appropriate to the way we need to treat such men in 2020 (or perhaps even today). … READ MORE …
Filed under: Uncategorized | Tagged: age, elderly, high, localized, risk, Treatment | 2 Comments »
Posted on April 13, 2010 by Sitemaster
A Prostate Cancer Task Force of the International Society of Geriatric Oncology (SIOG) has just issued new recommendations on the management of prostate cancer in “older men” (by which the task force means men of more than 70 years of age). … READ MORE …
Filed under: Management, Treatment | Tagged: elderly, geriatric, older, Treatment | Leave a comment »
Posted on March 26, 2010 by Sitemaster
New data from a series of > 700 elderly patients with high-risk prostate cancer suggests that aggressive combination therapy for such men is associated with a reduced risk for prostate cancer-specific mortality. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: "high risk", ADT, androgen deprivation therapy, brachytherapy, elderly, external beam radiation therapy, mortality | Leave a comment »